Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Osteoporosis

  Free Subscription


Articles published in J Bone Miner Res

Retrieve available abstracts of 157 articles:
HTML format



Single Articles


    November 2022
  1. BOTT KN, Feldman E, de Souza RJ, Comelli EM, et al
    Lipopolysaccharide induced bone loss in rodent models: a systematic review and meta-analysis.
    J Bone Miner Res. 2022 Nov 19. doi: 10.1002/jbmr.4740.
    PubMed     Abstract available


  2. AGARWAL S, Shiau S, Kamanda-Kosseh M, Bucovsky M, et al
    Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT.
    J Bone Miner Res. 2022 Nov 6. doi: 10.1002/jbmr.4739.
    PubMed     Abstract available


    October 2022
  3. CLARKE BL
    Economic Costs of Severe Osteoporotic Fractures Continue to Increase at Expense of Refracture.
    J Bone Miner Res. 2022 Oct 17. doi: 10.1002/jbmr.4713.
    PubMed    


  4. THOMAS T, Tubach F, Bizouard G, Crochard A, et al
    The economic burden of severe osteoporotic fractures in the French healthcare database: the FRACTOS study.
    J Bone Miner Res. 2022 Oct 6. doi: 10.1002/jbmr.4720.
    PubMed     Abstract available


  5. CZERWINSKI E, Cardona J, Plebanski R, Recknor C, et al
    The Efficacy and Safety of Abaloparatide-SC in Men with Osteoporosis: A Randomized Clinical Trial.
    J Bone Miner Res. 2022 Oct 3. doi: 10.1002/jbmr.4719.
    PubMed     Abstract available


  6. KJELDGAARD HK, Meyer HE, O'Flaherty M, Apalset EM, et al
    Impact of Total Hip Replacements on the Incidence of Hip Fractures in Norway During 1999-2019. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study.
    J Bone Miner Res. 2022;37:1936-1943.
    PubMed     Abstract available


    September 2022
  7. CHATTARIS T, Oh G, Gouskova NA, Kim DH, et al
    Osteoporosis Medications Prevent Subsequent Fracture in Frail Older Adults.
    J Bone Miner Res. 2022 Sep 27. doi: 10.1002/jbmr.4693.
    PubMed     Abstract available


  8. CLEMENTS M, Heffernan M, Ward M, Hoey L, et al
    A 2-year randomized controlled trial with low-dose B-vitamin supplementation shows benefits on bone mineral density in adults with lower B12 status.
    J Bone Miner Res. 2022 Sep 21. doi: 10.1002/jbmr.4709.
    PubMed     Abstract available


  9. COSMAN F, Huang S, McDermott M, Cummings SR, et al
    Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses.
    J Bone Miner Res. 2022 Sep 11. doi: 10.1002/jbmr.4705.
    PubMed     Abstract available


  10. RALSTON KAP, Hauser B, Paskins Z, Ralston SH, et al
    Effective Communication and the Osteoporosis Care Gap.
    J Bone Miner Res. 2022 Sep 8. doi: 10.1002/jbmr.4701.
    PubMed     Abstract available


  11. EASTELL R, Vittinghoff E, Lui LY, Ewing SK, et al
    Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk.
    J Bone Miner Res. 2022 Sep 6. doi: 10.1002/jbmr.4697.
    PubMed     Abstract available


    August 2022
  12. PEPE J, Rossi M, Battafarano G, Vernocchi P, et al
    Characterization of extracellular vesicles in osteoporotic patients compared to osteopenic and healthy controls.
    J Bone Miner Res. 2022 Aug 28. doi: 10.1002/jbmr.4688.
    PubMed     Abstract available


  13. JIANG C, Yan C, Duan J
    Bone Mineral Density Is Inversely Associated With Mortality in Chronic Kidney Disease Patients: A Meta-Analysis.
    J Bone Miner Res. 2022 Aug 19. doi: 10.1002/jbmr.4681.
    PubMed     Abstract available


  14. REID IR, Bastin S, Horne AM, Mihov B, et al
    Zoledronate Reduces Height Loss Independently of Vertebral Fracture Occurrence in a Randomized Trial in Osteopenic Older Women.
    J Bone Miner Res. 2022 Aug 19. doi: 10.1002/jbmr.4684.
    PubMed     Abstract available


  15. HOFFMANN I, Shojaa M, Kohl M, von Stengel S, et al
    Exercise Reduces the Number of Overall and Major Osteoporotic Fractures in Adults. Does Supervision Make a Difference? Systematic Review and Meta-Analysis.
    J Bone Miner Res. 2022 Aug 19. doi: 10.1002/jbmr.4683.
    PubMed     Abstract available


  16. COSTANTINI A, Makitie RE, Hartmann MA, Fratzl-Zelman N, et al
    Early-onset osteoporosis: Rare monogenic forms elucidate the complexity of disease pathogenesis beyond type I collagen.
    J Bone Miner Res. 2022 Aug 10. doi: 10.1002/jbmr.4668.
    PubMed     Abstract available


  17. LESLIE WD, Morin SN, Lix LM, McCloskey EV, et al
    Effect of Discordant Hip Bone Density on Incident Fracture Risk: A Registry-Based Cohort Study.
    J Bone Miner Res. 2022 Aug 10. doi: 10.1002/jbmr.4672.
    PubMed     Abstract available


  18. VRANKEN L, de Bruin IJA, Driessen AHM, Geusens PPM, et al
    Decreased Mortality and Subsequent Fracture Risk in Patients With a Major and Hip Fracture After the Introduction of a Fracture Liaison Service: A 3-Year Follow-Up Survey.
    J Bone Miner Res. 2022 Aug 10. doi: 10.1002/jbmr.4674.
    PubMed     Abstract available


  19. WATTS NB
    Romosozumab and Renal Function.
    J Bone Miner Res. 2022;37:1435-1436.
    PubMed    


  20. ABOOD A, Mesner L, Rosenow W, Al-Barghouthi BM, et al
    Identification of Known and Novel Long Noncoding RNAs Potentially Responsible for the Effects of Bone Mineral Density (BMD) Genomewide Association Study (GWAS) Loci.
    J Bone Miner Res. 2022;37:1500-1510.
    PubMed     Abstract available


    July 2022
  21. CHERIAN KE, Kapoor N, Paul TV
    Disrupted sleep architecture is associated with incident bone loss in Indian postmenopausal women: a prospective study.
    J Bone Miner Res. 2022 Jul 26. doi: 10.1002/jbmr.4662.
    PubMed     Abstract available


  22. PHAN QT, Chua KY, Jin A, Winkler C, et al
    CXCL9 predicts the risk of osteoporotic hip fracture in a prospective cohort of Chinese men - a matched case-control study.
    J Bone Miner Res. 2022 Jul 10. doi: 10.1002/jbmr.4646.
    PubMed     Abstract available


  23. PEREZ-CASTRILLON JL, Duenas-Laita A, Gomez-Alonso C, Bouillon R, et al
    Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women.
    J Bone Miner Res. 2022;37:1413-1415.
    PubMed    


  24. SOSA-HENRIQUEZ M, de Tejada-Romero MAJG, Cancelo-Hidalgo MAJ, Diaz-Guerra GM, et al
    Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women.
    J Bone Miner Res. 2022;37:1411-1412.
    PubMed    


    June 2022
  25. BUETTMANN EG, Goldscheitter GM, Hoppock GA, Friedman MA, et al
    Similarities Between Disuse and Age-Induced Bone Loss.
    J Bone Miner Res. 2022 Jun 30. doi: 10.1002/jbmr.4643.
    PubMed     Abstract available


  26. GKOUVERIS I, Hadaya D, Elzakra N, Soundia A, et al
    Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.
    J Bone Miner Res. 2022 Jun 16. doi: 10.1002/jbmr.4637.
    PubMed     Abstract available


  27. KORHONEN MT, Kujala UM, Kettunen J, Korhonen OV, et al
    Longitudinal associations of high-volume and vigorous-intensity exercise with hip fracture risk in men.
    J Bone Miner Res. 2022 Jun 14. doi: 10.1002/jbmr.4624.
    PubMed     Abstract available


  28. GURUSAMY P, Larsen BA, Allen RT, Ward SR, et al
    Density and Fat Fraction of the Psoas, Paraspinal, and Oblique Muscle Groups are Associated with Lumbar Vertebral Bone Mineral Density in a Multi-Ethnic Community-Living Population: The Multi-Ethnic Study of Atherosclerosis.
    J Bone Miner Res. 2022 Jun 12. doi: 10.1002/jbmr.4634.
    PubMed     Abstract available


  29. TAI TW, Hwang JS, Li CC, Hsu JC, et al
    The impact of various anti-osteoporosis drugs on all-cause mortality after hip fractures: A nationwide population study.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4627.
    PubMed     Abstract available


  30. LU T, Forgetta V, Greenwood CMT, Richards JB, et al
    Identifying Causes of Fracture Beyond Bone Mineral Density: Evidence from Human Genetics.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4632.
    PubMed     Abstract available


  31. DAHL C, Madsen C, Omsland TK, Sogaard AJ, et al
    The Association of Cold Ambient Temperature with Fracture Risk and Mortality: National data from Norway - A NOREPOS* Study.
    J Bone Miner Res. 2022 Jun 11. doi: 10.1002/jbmr.4628.
    PubMed     Abstract available


  32. SU Y, Yeung SSY, Chen YM, Leung JCS, et al
    The Associations of Dietary Inflammatory Potential With Musculoskeletal Health in Chinese Community-Dwelling Older People: The Mr. OS and Ms. OS (Hong Kong) Cohort Study.
    J Bone Miner Res. 2022;37:1179-1187.
    PubMed     Abstract available


    May 2022
  33. LEBLANC ES, Hovey KM, Cauley JA, Stefanick M, et al
    Cumulative Endogenous Estrogen Exposure is Associated with Postmenopausal Fracture Risk: The Women's Health Initiative Study.
    J Bone Miner Res. 2022 May 29. doi: 10.1002/jbmr.4613.
    PubMed     Abstract available


  34. SOLLMANN N, Loffler MT, El Husseini M, Sekuboyina A, et al
    Automated opportunistic osteoporosis screening in routine computed tomography of the spine - comparison with dedicated quantitative CT.
    J Bone Miner Res. 2022 May 22. doi: 10.1002/jbmr.4575.
    PubMed     Abstract available


  35. WILLIAMS DW, Ho K, Lenon A, Kim S, et al
    Long-term ligature-induced periodontitis exacerbates development of bisphosphonate-related osteonecrosis of the jaw in mice.
    J Bone Miner Res. 2022 May 22. doi: 10.1002/jbmr.4614.
    PubMed     Abstract available


  36. ODA T, Jodicke AM, Robinson DE, Delmestri A, et al
    Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self-controlled case series in the UK.
    J Bone Miner Res. 2022 May 17. doi: 10.1002/jbmr.4573.
    PubMed     Abstract available


  37. BAILEY S, Stadelmann MA, Zysset PK, Vashishth D, et al
    Influence of Metastatic Bone Lesion Type and Tumor Origin on Human Vertebral Bone Architecture, Matrix Quality, and Mechanical Properties.
    J Bone Miner Res. 2022;37:896-907.
    PubMed     Abstract available


  38. FARLAY D, Rizzo S, Dempster DW, Huang S, et al
    Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years.
    J Bone Miner Res. 2022;37:856-864.
    PubMed     Abstract available


    April 2022
  39. VISSER JA
    Serum AMH levels: an early reproductive marker for bone loss?
    J Bone Miner Res. 2022 Apr 30. doi: 10.1002/jbmr.4567.
    PubMed    


  40. MILLER PD, Adachi JD, Albergaria BH, Cheung AM, et al
    Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
    J Bone Miner Res. 2022 Apr 24. doi: 10.1002/jbmr.4563.
    PubMed     Abstract available


  41. ZHENG Z, Johansson H, Harvey NC, Lorentzon M, et al
    Potential Adverse Effect of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) on Bisphosphonate Efficacy: An Exploratory Post Hoc Analysis From a Randomized Controlled Trial of Clodronate.
    J Bone Miner Res. 2022 Apr 20. doi: 10.1002/jbmr.4548.
    PubMed     Abstract available


  42. ZHU DL, Chen XF, Zhou XR, Hu SY, et al
    An osteoporosis susceptibility allele at 11p15 regulates SOX6 expression by modulating TCF4 chromatin binding.
    J Bone Miner Res. 2022 Apr 4. doi: 10.1002/jbmr.4554.
    PubMed     Abstract available


  43. KARLAMANGLA AS, Shieh A, Greendale GA, Yu EW, et al
    Anti-Mullerian Hormone as Predictor of Future and Ongoing Bone Loss During the Menopause Transition.
    J Bone Miner Res. 2022 Apr 4. doi: 10.1002/jbmr.4525.
    PubMed     Abstract available


  44. LI R, Medina-Gomez C, Rivadeneira F
    Down-to-Earth Studies of the Gut Microbiome in Bone Health and Disease.
    J Bone Miner Res. 2022;37:595-596.
    PubMed    


  45. ORWOLL ES, Parimi N, Wiedrick J, Lapidus J, et al
    Analysis of the Associations Between the Human Fecal Microbiome and Bone Density, Structure, and Strength: The Osteoporotic Fractures in Men (MrOS) Cohort.
    J Bone Miner Res. 2022;37:597-607.
    PubMed     Abstract available


    March 2022
  46. KATO H, Ansh AJ, Lester ER, Kinoshita Y, et al
    Identification of ENPP1 haploinsufficiency in patients with diffuse idiopathic skeletal hyperostosis and early-onset osteoporosis.
    J Bone Miner Res. 2022 Mar 26. doi: 10.1002/jbmr.4550.
    PubMed     Abstract available


  47. GEUSENS P, Bevers MSAM, van Rietbergen B, Messina OD, et al
    Effect of denosumab compared to risedronate on bone strength in patients initiating or continuing glucocorticoid treatment.
    J Bone Miner Res. 2022 Mar 26. doi: 10.1002/jbmr.4551.
    PubMed     Abstract available


  48. CHANDRAN M, Ebeling PR, Mitchell PJ, Nguyen TV, et al
    Harmonization of osteoporosis guidelines. Paving the way for disrupting the status quo in osteoporosis management in the Asia Pacific.
    J Bone Miner Res. 2022 Mar 12. doi: 10.1002/jbmr.4544.
    PubMed     Abstract available


  49. CHANDRA A, Lagnado AB, Farr JN, Schleusner M, et al
    Bone marrow adiposity in models of radiation- and aging-related bone loss is dependent on cellular senescence.
    J Bone Miner Res. 2022 Mar 5. doi: 10.1002/jbmr.4537.
    PubMed     Abstract available


  50. ADAMI G, Fassio A, Gatti D, Viapiana O, et al
    Acute Phase Reaction and Fracture Risk Reduction. Are Gamma-Delta T Cells and hypovitaminosis D the Missing Link?
    J Bone Miner Res. 2022 Mar 1. doi: 10.1002/jbmr.4534.
    PubMed    


  51. ZHANG L, Fu X, Ni L, Liu C, et al
    Hedgehog Signaling Controls Bone Homeostasis by Regulating Osteogenic/Adipogenic Fate of Skeletal Stem/Progenitor Cells in Mice.
    J Bone Miner Res. 2022;37:559-576.
    PubMed     Abstract available


    February 2022
  52. BLIUC D, Tran T, Adachi JD, Atkins GJ, et al
    The association between cognitive decline and bone loss and fracture risk is not affected by medication with anticholinergic effect.
    J Bone Miner Res. 2022 Feb 23. doi: 10.1002/jbmr.4530.
    PubMed    


  53. POOLE KE, Treece GM, Pearson RA, Gee AH, et al
    Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density.
    J Bone Miner Res. 2022;37:256-264.
    PubMed     Abstract available


    January 2022
  54. KAYA S, Schurman CA, Dole NS, Evans DS, et al
    Prioritization of genes relevant to bone fragility through the unbiased integration of aging mouse bone transcriptomics and human GWAS analyses.
    J Bone Miner Res. 2022 Jan 29. doi: 10.1002/jbmr.4516.
    PubMed     Abstract available


  55. NAHARCI MI
    Comment on a recent article titled "Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study".
    J Bone Miner Res. 2022 Jan 23. doi: 10.1002/jbmr.4510.
    PubMed    


  56. SADOUGHI S, Pasco C, Joseph GB, Wu PH, et al
    Cortical bone loss following gastric bypass surgery is not primarily endocortical.
    J Bone Miner Res. 2022 Jan 23. doi: 10.1002/jbmr.4512.
    PubMed     Abstract available


  57. TSOURDI E
    RANKL blockade reduces cachexia and bone loss induced by non-metastatic ovarian cancer in mice - Editorial.
    J Bone Miner Res. 2022 Jan 23. doi: 10.1002/jbmr.4511.
    PubMed    


  58. WOODS GN, Ewing SK, Schafer AL, Gudnason V, et al
    Saturated and Unsaturated Bone Marrow Lipids Have Distinct Effects on Bone Density and Fracture Risk in Older Adults.
    J Bone Miner Res. 2022 Jan 17. doi: 10.1002/jbmr.4504.
    PubMed     Abstract available


  59. WU KC, Black DM
    A Perspective on Postmenopausal Bone Loss with Aging.
    J Bone Miner Res. 2022 Jan 5. doi: 10.1002/jbmr.4499.
    PubMed    


  60. ERIKSEN EF, Chapurlat R, Boyce RW, Shi Y, et al
    Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial.
    J Bone Miner Res. 2022;37:36-40.
    PubMed     Abstract available


  61. ICONARU L, Charles A, Baleanu F, Surquin M, et al
    Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee Cohort.
    J Bone Miner Res. 2022;37:59-67.
    PubMed     Abstract available


  62. MA Q, Wang S, Xie Z, Shen Y, et al
    The SFRP1 Inhibitor WAY-316606 Attenuates Osteoclastogenesis Through Dual Modulation of Canonical Wnt Signaling.
    J Bone Miner Res. 2022;37:152-166.
    PubMed     Abstract available


    December 2021
  63. WHITTIER DE, Samelson EJ, Hannan MT, Burt LA, et al
    Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk.
    J Bone Miner Res. 2021 Dec 25. doi: 10.1002/jbmr.4494.
    PubMed     Abstract available


  64. KASHER M, Freidin MB, Williams FM, Cherny SS, et al
    Shared genetic architecture between rheumatoid arthritis and varying osteoporotic phenotypes.
    J Bone Miner Res. 2021 Dec 15. doi: 10.1002/jbmr.4491.
    PubMed     Abstract available


  65. PIN F, Jones AJ, Huot JR, Narasimhan A, et al
    RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.
    J Bone Miner Res. 2021 Dec 13. doi: 10.1002/jbmr.4480.
    PubMed     Abstract available


  66. CHEUNG WH, Hung VW, Cheuk KY, Chau WW, et al
    Best Performance Parameters of HR-pQCT to Predict Fragility Fracture: Systematic Review and Meta-Analysis.
    J Bone Miner Res. 2021;36:2381-2398.
    PubMed     Abstract available


  67. LIU J, Laster A, Xu X, Guo H, et al
    Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries.
    J Bone Miner Res. 2021;36:2309-2316.
    PubMed     Abstract available


    November 2021
  68. ALAJLOUNI D, Tran T, Bliuc D, Blank RD, et al
    Muscle Strength and Physical Performance Improve Fracture Risk Prediction beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2021 Nov 29. doi: 10.1002/jbmr.4483.
    PubMed     Abstract available


  69. OTT SM
    Consider the bisphosphonate dose.
    J Bone Miner Res. 2021 Nov 29. doi: 10.1002/jbmr.4479.
    PubMed    


  70. DHALIWAL R, Ewing SK, Vashishth D, Semba RD, et al
    Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes.
    J Bone Miner Res. 2021 Nov 24. doi: 10.1002/jbmr.4466.
    PubMed     Abstract available


  71. JANG M, Kim M, Bae SJ, Lee SH, et al
    Opportunistic osteoporosis screening using chest radiographs with deep learning: Development and external validation with a cohort dataset.
    J Bone Miner Res. 2021 Nov 23. doi: 10.1002/jbmr.4477.
    PubMed     Abstract available


  72. KIM HJ, Ryu KY, Kim YG, Kim MO, et al
    Myeloid-specific PTP1B deficiency attenuates inflammation- and ovariectomy-induced bone loss in mice by inhibiting osteoclastogenesis.
    J Bone Miner Res. 2021 Nov 23. doi: 10.1002/jbmr.4478.
    PubMed     Abstract available


  73. JUDITH EG, Daniel L, John-Patrik B, Benoit S, et al
    Risk of Osteonecrosis of the Jaw under Denosumab Compared to Bisphosphonates in Patients with Osteoporosis.
    J Bone Miner Res. 2021 Nov 17. doi: 10.1002/jbmr.4472.
    PubMed     Abstract available


  74. TSUJITA M, Doi Y, Obi Y, Hamano T, et al
    Cholecalciferol supplementation attenuates bone loss in incident kidney transplant recipients: A prespecified secondary endpoint analysis of a randomized controlled trial.
    J Bone Miner Res. 2021 Nov 8. doi: 10.1002/jbmr.4469.
    PubMed     Abstract available


  75. BROWN JP, Engelke K, Keaveny TM, Chines A, et al
    Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
    J Bone Miner Res. 2021;36:2139-2152.
    PubMed     Abstract available


    October 2021
  76. GREGSON CL, Madanhire T, Rehman A, Ferrand RA, et al
    Osteoporosis, rather than sarcopenia, is the predominant musculoskeletal disease in a rural South African community where HIV prevalence is high: a cross-sectional study.
    J Bone Miner Res. 2021 Oct 25. doi: 10.1002/jbmr.4464.
    PubMed     Abstract available


  77. BEGIN MJ, Audet MC, Chevalley T, Portela M, et al
    Fracture risk following an atypical femoral fracture.
    J Bone Miner Res. 2021 Oct 20. doi: 10.1002/jbmr.4461.
    PubMed     Abstract available


  78. MOILANEN A, Kopra J, Kroger H, Sund R, et al
    Characteristics of Long-Term Femoral Neck Bone Loss in Postmenopausal Women: A 25-Year Follow-Up.
    J Bone Miner Res. 2021 Oct 19. doi: 10.1002/jbmr.4444.
    PubMed     Abstract available


  79. FISCHER V, Ragipoglu D, Diedrich J, Steppe L, et al
    Mast cells trigger disturbed bone healing in osteoporotic mice.
    J Bone Miner Res. 2021 Oct 11. doi: 10.1002/jbmr.4455.
    PubMed     Abstract available


  80. FUSARO M, Cianciolo G, Tripepi G, Plebani M, et al
    Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study.
    J Bone Miner Res. 2021 Oct 8. doi: 10.1002/jbmr.4440.
    PubMed     Abstract available


  81. VERWAAIJEN EJ, Ma J, de Groot-Kruseman HA, Pieters R, et al
    A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.
    J Bone Miner Res. 2021 Oct 5. doi: 10.1002/jbmr.4442.
    PubMed     Abstract available


  82. NOEL SE, Santos MP, Wright NC
    Racial and Ethnic Disparities in Bone Health and Outcomes in the United States.
    J Bone Miner Res. 2021;36:1881-1905.
    PubMed     Abstract available


  83. ZWEIFLER LE, Koh AJ, Daignault-Newton S, McCauley LK, et al
    Anabolic actions of PTH in murine models: two decades of insights.
    J Bone Miner Res. 2021;36:1979-1998.
    PubMed     Abstract available


    September 2021
  84. SKULADOTTIR SS, Ramel A, Eymundsdottir H, Hjaltadottir I, et al
    Serum 25-hydroxy-vitamin D status and incident hip fractures in elderly adults: Looking beyond bone mineral density.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4450.
    PubMed    


  85. BANEFELT J, Timoshanko J, Soreskog E, Ortsater G, et al
    Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4448.
    PubMed     Abstract available


  86. GREY A, Bolland MJ, Horne A, Mihov B, et al
    Bone mineral density and bone turnover ten years after a single 5mg dose or two 5-yearly lower doses of zoledronate in osteopenic older women: an open-label extension of a randomized controlled trial.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4453.
    PubMed     Abstract available


  87. BLACK DM, Reid IR, Napoli N, Ewing SK, et al
    The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.
    J Bone Miner Res. 2021 Sep 28. doi: 10.1002/jbmr.4434.
    PubMed     Abstract available


  88. SINGHANIA P, Bhattacharjee R
    Letter to editor regarding "Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: A randomized, controlled trial" by W. Brent Edwards.
    J Bone Miner Res. 2021 Sep 20. doi: 10.1002/jbmr.4446.
    PubMed    


  89. LARY CW, Rosen CJ, Kiel DP
    Osteoporosis and dementia: establishing a link.
    J Bone Miner Res. 2021 Sep 13. doi: 10.1002/jbmr.4431.
    PubMed    


  90. BEAUDOIN C, Jean S, Moore L, Gamache P, et al
    Prediction of Osteoporotic Fractures in Elderly Individuals: a Derivation and Internal Validation Study Using Healthcare Administrative Data.
    J Bone Miner Res. 2021 Sep 7. doi: 10.1002/jbmr.4438.
    PubMed     Abstract available


    August 2021
  91. GINSBERG C, Hoofnagle AN, Katz R, Hughes-Austin J, et al
    The Vitamin D Metabolite Ratio is Associated with Changes in Bone Density and Fracture Risk in Older Adults.
    J Bone Miner Res. 2021 Aug 23. doi: 10.1002/jbmr.4426.
    PubMed     Abstract available



  92. Retraction Statement: Bone Mineral Density Predicts Fractures in Chronic Kidney Disease.
    J Bone Miner Res. 2021 Aug 19. doi: 10.1002/jbmr.4421.
    PubMed    


  93. DEGLI ESPOSTI L, Perrone V, Sangiorgi D, Andretta M, et al
    The Use of Oral Amino-Bisphosphonates and COVID-19 Outcomes.
    J Bone Miner Res. 2021 Aug 18. doi: 10.1002/jbmr.4419.
    PubMed     Abstract available


  94. HAINES MS, Kimball A, Meenaghan E, Bachmann KN, et al
    Sequential therapy with recombinant human IGF-1 followed by risedronate increases spine bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled trial.
    J Bone Miner Res. 2021 Aug 6. doi: 10.1002/jbmr.4420.
    PubMed     Abstract available


  95. KHALID S, Pineda Moncusi M, El-Hussein L, Delmestri A, et al
    Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models.
    J Bone Miner Res. 2021 Aug 3. doi: 10.1002/jbmr.4414.
    PubMed     Abstract available


  96. KLINE GA, Lix LM, Leslie WD
    Patient Outcomes in the Years After a DXA-BMD Treatment Monitoring Test: Improved Medication Adherence in Some, But Too Little Too Late.
    J Bone Miner Res. 2021;36:1425-1431.
    PubMed     Abstract available


    July 2021
  97. BLIUC D, Tran T, Adachi JD, Atkins GJ, et al
    Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study.
    J Bone Miner Res. 2021 Jul 20. doi: 10.1002/jbmr.4402.
    PubMed     Abstract available


  98. BATOON L, Millard SM, Raggatt LJ, Wu AC, et al
    Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model.
    J Bone Miner Res. 2021 Jul 19. doi: 10.1002/jbmr.4413.
    PubMed     Abstract available


  99. EDWARDS WB, Haider IT, Simonian N, Barroso J, et al
    Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: A randomized, controlled trial.
    J Bone Miner Res. 2021 Jul 19. doi: 10.1002/jbmr.4416.
    PubMed     Abstract available


    June 2021
  100. CHEN J, Zhang J, So HC, Ai S, et al
    Association of sleep traits and heel bone mineral density: Observational and Mendelian randomization studies.
    J Bone Miner Res. 2021 Jun 29. doi: 10.1002/jbmr.4406.
    PubMed     Abstract available


  101. MICHAELSSON K, Byberg L, Svennblad B, Larsson SC, et al
    Serum 25-hydroxyvitamin D is associated with fracture risk only during periods of seasonally high levels in women with a high BMI.
    J Bone Miner Res. 2021 Jun 25. doi: 10.1002/jbmr.4400.
    PubMed     Abstract available


  102. DOWNEY J
    Erratum for Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women.
    J Bone Miner Res. 2021 Jun 22. doi: 10.1002/jbmr.4392.
    PubMed    


  103. CHAKHTOURA M, Dagher H, Sharara S, Ajjour S, et al
    Systematic review of major osteoporotic fracture to hip fracture incidence rate ratios worldwide: Implications to FRAX derived estimates.
    J Bone Miner Res. 2021 Jun 21. doi: 10.1002/jbmr.4395.
    PubMed     Abstract available


  104. REID IR
    Monitoring Osteoporosis Therapy.
    J Bone Miner Res. 2021 Jun 16. doi: 10.1002/jbmr.4393.
    PubMed    


  105. YU XH, Wei YY, Zeng P, Lei SF, et al
    Birth weight is positively associated with adult osteoporosis risk: observational and Mendelian randomization studies.
    J Bone Miner Res. 2021 Jun 9. doi: 10.1002/jbmr.4316.
    PubMed     Abstract available


  106. BANDO K, Kuroishi T, Tada H, Oizumi T, et al
    Nitrogen-containing Bisphosphonates and Lipopolysaccharide Mutually Augment Inflammation via ATP- and IL-1beta-mediated Production of NETs.
    J Bone Miner Res. 2021 Jun 2. doi: 10.1002/jbmr.4384.
    PubMed     Abstract available


    May 2021
  107. KISTLER-FISCHBACHER M, Yong JS, Weeks BK, Beck BR, et al
    A Comparison of Bone-Targeted Exercise With and Without Antiresorptive Bone Medication to Reduce Indices of Fracture Risk in Postmenopausal Women With Low Bone Mass: The MEDEX-OP Randomized Controlled Trial.
    J Bone Miner Res. 2021 May 25. doi: 10.1002/jbmr.4334.
    PubMed     Abstract available


  108. DUTTA A, Bhadada SK, Walia R
    Anabolic Window-Like Phenomenon After Biochemical Remission in Cushing's Syndrome: Does Surge in Bone Turnover Markers Correlate With Improved Bone Mineral Density?
    J Bone Miner Res. 2021 May 24. doi: 10.1002/jbmr.4337.
    PubMed    


  109. BEK JW, Shochat C, De Clercq A, De Saffel H, et al
    Lrp5 mutant and crispant zebrafish faithfully model human osteoporosis, establishing the zebrafish as a platform for CRISPR-based functional screening of osteoporosis candidate genes.
    J Bone Miner Res. 2021 May 6. doi: 10.1002/jbmr.4327.
    PubMed     Abstract available


  110. WANG S, Ma Q, Xie Z, Shen Y, et al
    An anti-oxidant sesquiterpene inhibits osteoclastogenesis via blocking IPMK/TRAF6 and counteracts OVX-induced osteoporosis in mice.
    J Bone Miner Res. 2021 May 6. doi: 10.1002/jbmr.4328.
    PubMed     Abstract available


  111. RAMCHAND SK, David NL, Lee H, Eastell R, et al
    Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.
    J Bone Miner Res. 2021;36:921-930.
    PubMed     Abstract available


    April 2021
  112. JOHANSSON L, Lorentzon M
    Reply to: Grade 1 vertebral fractures, bone mineral density, and the risk of fractures.
    J Bone Miner Res. 2021 Apr 26. doi: 10.1002/jbmr.4301.
    PubMed    


  113. KHAIRALLAH P, Nickolas TL
    Bisphosphonates in Kidney Disease-Safety First.
    J Bone Miner Res. 2021 Apr 26. doi: 10.1002/jbmr.4283.
    PubMed    


  114. KANTEREWICZ E, Puigoriol E, Peris P
    Grade 1 vertebral fractures, bone mineral density, and the risk of fractures.
    J Bone Miner Res. 2021 Apr 20. doi: 10.1002/jbmr.4302.
    PubMed    


  115. BONNET N, Douni E, Perreard Lopreno G, Besse M, et al
    RANKL-induced increase in cathepsin K levels restricts cortical expansion in a periostin dependent fashion: a potential new mechanism of bone fragility.
    J Bone Miner Res. 2021 Apr 15. doi: 10.1002/jbmr.4307.
    PubMed     Abstract available


  116. TSOURDI E, Yu EW, Jan de Beur SM, Drake MT, et al
    Vaccination for Covid-19 and relationship to osteoporosis care: Current evidence and suggested approaches.
    J Bone Miner Res. 2021 Apr 8. doi: 10.1002/jbmr.4304.
    PubMed     Abstract available


  117. HARVEY NC, Orwoll E, Kwok T, Karlsson MK, et al
    Sarcopenia Definitions as Predictors of Fracture Risk Independent of FRAX((R)) , Falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study: A Meta-Analysis.
    J Bone Miner Res. 2021 Apr 8. doi: 10.1002/jbmr.4293.
    PubMed     Abstract available


  118. SOLLING AS, Harslof T, Langdahl B
    Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-year randomized study.
    J Bone Miner Res. 2021 Apr 4. doi: 10.1002/jbmr.4305.
    PubMed     Abstract available


    March 2021
  119. MA B, Li C, Pan J, Zhang S, et al
    Causal Associations of Anthropometric Measurements with Fracture Risk and Bone Mineral Density: A Mendelian Randomization Study.
    J Bone Miner Res. 2021 Mar 30. doi: 10.1002/jbmr.4296.
    PubMed     Abstract available


  120. MA J, Siminoski K, Wang P, Jaremko JL, et al
    The Accuracy of Incident Vertebral Fracture Detection in Children Using Targeted Case-Finding Approaches.
    J Bone Miner Res. 2021 Mar 30. doi: 10.1002/jbmr.4294.
    PubMed     Abstract available


  121. SMETS J, Shevroja E, Hugle T, Leslie WD, et al
    Machine learning Solutions for Osteoporosis - a Review.
    J Bone Miner Res. 2021 Mar 22. doi: 10.1002/jbmr.4292.
    PubMed     Abstract available


  122. SCHOUSBOE JT, Langsetmo L, Szulc P, Lewis JR, et al
    Joint Associations of Prevalent Radiographic Vertebral Fracture and Abdominal Aortic Calcification With Incident Hip, Major Osteoporotic, and Clinical Vertebral Fractures.
    J Bone Miner Res. 2021 Mar 17. doi: 10.1002/jbmr.4257.
    PubMed     Abstract available


  123. PAPAPOULOS S, Bone H, Cosman F, Dempster DW, et al
    Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women with Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.
    J Bone Miner Res. 2021 Mar 16. doi: 10.1002/jbmr.4284.
    PubMed     Abstract available


  124. GANESAN C, Thomas IC, Romero R, Song S, et al
    Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease.
    J Bone Miner Res. 2021 Mar 3. doi: 10.1002/jbmr.4260.
    PubMed     Abstract available


  125. SENAY A, Fernandes JC, Delisle J, Morin SN, et al
    Patient Healthcare Trajectory and its Impact on the Cost-Effectiveness of Fracture Liaison Services.
    J Bone Miner Res. 2021;36:459-468.
    PubMed     Abstract available


    February 2021
  126. ENSRUD KE, Schousboe JT, Kats AM, Vo TN, et al
    Height Loss in Old Age and Fracture Risk Among Men in Late Life: A Prospective Cohort Study.
    J Bone Miner Res. 2021 Feb 22. doi: 10.1002/jbmr.4278.
    PubMed     Abstract available


  127. COLAIANNI G, Errede M, Sanesi L, Notarnicola A, et al
    In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts.
    J Bone Miner Res. 2021 Feb 18. doi: 10.1002/jbmr.4268.
    PubMed    


  128. SCHOUSBOE JT, Ensrud KE
    Opportunistic Osteoporosis Screening Using Low-Dose Computed Tomography (LDCT): Promising Strategy, but Challenges Remain.
    J Bone Miner Res. 2021 Feb 18. doi: 10.1002/jbmr.4266.
    PubMed    


  129. WEIGL M, Kocijan R, Ferguson J, Leinfellner G, et al
    Longitudinal Changes of Circulating miRNAs during Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal Osteoporosis.
    J Bone Miner Res. 2021 Feb 17. doi: 10.1002/jbmr.4276.
    PubMed     Abstract available


  130. FOLKESTAD L, Stochholm K, Groth K, Hove H, et al
    Fracture Rates and Fracture Risk in Patients With Marfan Syndrome: A Nationwide Register-Based Cohort Study.
    J Bone Miner Res. 2021 Feb 10. doi: 10.1002/jbmr.4258.
    PubMed     Abstract available


  131. MAZESS RB
    Vitamin D Supplements: Is Bone Loss by pQCT Really Negative?
    J Bone Miner Res. 2021 Feb 3. doi: 10.1002/jbmr.4246.
    PubMed    


  132. BURT LA, Billington EO, Rose MS, Kremer R, et al
    Reply to Vitamin D Supplements: Is Bone Loss by HR-pQCT Really Negative?
    J Bone Miner Res. 2021 Feb 3. doi: 10.1002/jbmr.4247.
    PubMed    


  133. LEWIS JR, Voortman T, Ioannidis JP
    Evaluating and Strengthening the Evidence for Nutritional Bone Research: Ready to Break New Ground?
    J Bone Miner Res. 2021;36:219-226.
    PubMed     Abstract available


  134. GILSENAN A, Midkiff K, Harris D, Kellier-Steele N, et al
    Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study.
    J Bone Miner Res. 2021;36:244-251.
    PubMed     Abstract available


    January 2021
  135. LU H, Lei X, Zhao H, Elting L, et al
    Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy is Associated with Decreased Fractures in Women with Breast Cancer.
    J Bone Miner Res. 2021 Jan 23. doi: 10.1002/jbmr.4250.
    PubMed     Abstract available


  136. BING L, Jie Z, Jianxiong M, Weibo C, et al
    Crosstalk between histone and DNA methylation mediates bone loss in hind limb unloading.
    J Bone Miner Res. 2021 Jan 19. doi: 10.1002/jbmr.4253.
    PubMed     Abstract available


  137. DEMPSTER DW, Zhou H, Rao SD, Recknor C, et al
    Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women with Osteoporosis.
    J Bone Miner Res. 2021 Jan 12. doi: 10.1002/jbmr.4243.
    PubMed     Abstract available


  138. ZHANG X, Xu H, Li GHY, Long MT, et al
    Metabolomics insights into osteoporosis through association with bone mineral density.
    J Bone Miner Res. 2021 Jan 12. doi: 10.1002/jbmr.4240.
    PubMed     Abstract available


  139. FARLAY D, Rizzo S, Ste-Marie LG, Michou L, et al
    Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture.
    J Bone Miner Res. 2021 Jan 12. doi: 10.1002/jbmr.4244.
    PubMed     Abstract available


    December 2020
  140. HAYES KN, Giannakeas V, Wong AKO
    Response to: Challenges to the Possible Use of Bisphosphonates in Early-Stage Osteoarthritis.
    J Bone Miner Res. 2020 Dec 30. doi: 10.1002/jbmr.4232.
    PubMed    


  141. ROBINSON DE, Ali MS, Pallares N, Tebe C, et al
    Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis.
    J Bone Miner Res. 2020 Dec 29. doi: 10.1002/jbmr.4235.
    PubMed     Abstract available


  142. IM C, Li N, Moon W, Liu Q, et al
    Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors.
    J Bone Miner Res. 2020 Dec 18. doi: 10.1002/jbmr.4234.
    PubMed     Abstract available


  143. RAJAPAKSE CS, Johncola AJ, Batzdorf AS, Jones BC, et al
    Effect of Low Intensity Vibration on Bone Strength, Microstructure, and Adiposity in Pre-Osteoporotic Postmenopausal Women: A Randomized Placebo-Controlled Trial.
    J Bone Miner Res. 2020 Dec 13. doi: 10.1002/jbmr.4229.
    PubMed     Abstract available


  144. NG CA, Scott D, Seibel MJ, Cumming RG, et al
    Higher Impact Physical Activity is Associated with Maintenance of Bone Mineral Density but Not Reduced Incident Falls or Fractures in Older Men: The Concord Health and Ageing in Men Project.
    J Bone Miner Res. 2020 Dec 5. doi: 10.1002/jbmr.4228.
    PubMed     Abstract available


    November 2020
  145. MOKHTARZADEH H, Anderson DE, Allaire BT, Bouxsein ML, et al
    Patterns of load-to-strength ratios along the spine in a population-based cohort to evaluate the contribution of spinal loading to vertebral fractures.
    J Bone Miner Res. 2020 Nov 30. doi: 10.1002/jbmr.4222.
    PubMed     Abstract available


  146. YAU MS, Kuipers AL, Price R, Nicolas A, et al
    A meta-analysis of the transferability of bone mineral density genetic loci associations from European to African ancestry populations.
    J Bone Miner Res. 2020 Nov 29. doi: 10.1002/jbmr.4220.
    PubMed     Abstract available


  147. BROMILEY PA, Clark EM, Poole KE
    Computer-Aided Diagnostic Systems for Osteoporotic Vertebral Fracture Detection: Opportunities and Challenges.
    J Bone Miner Res. 2020 Nov 14. doi: 10.1002/jbmr.4205.
    PubMed    


  148. FUSARO M, Cozzolino M, Plebani M, Iervasi G, et al
    Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI study.
    J Bone Miner Res. 2020 Nov 14. doi: 10.1002/jbmr.4214.
    PubMed     Abstract available


  149. ZHANG C, Zhu J, Jia J, Guan Z, et al
    Effect of Single Versus Multiple Fractures on Systemic Bone Loss in Mice.
    J Bone Miner Res. 2020 Nov 12. doi: 10.1002/jbmr.4211.
    PubMed     Abstract available


  150. CHENG X, Zhao K, Zha X, Du X, et al
    Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study.
    J Bone Miner Res. 2020 Nov 4. doi: 10.1002/jbmr.4187.
    PubMed     Abstract available


  151. SUGIYAMA T
    Effects of High-Dose Vitamin D Supplementation on Bone Fragility.
    J Bone Miner Res. 2020 Nov 2. doi: 10.1002/jbmr.4194.
    PubMed    


    October 2020
  152. LEE JM, Kim MJ, Lee SJ, Kim BG, et al
    PDK2 deficiency prevents ovariectomy-induced bone loss in mice by regulating the RANKL-NFATc1 pathway during osteoclastogenesis.
    J Bone Miner Res. 2020 Oct 30. doi: 10.1002/jbmr.4202.
    PubMed     Abstract available


  153. STURZNICKEL J, Rolvien T, Delsmann A, Butscheidt S, et al
    Clinical phenotype and relevance of LRP5 and LRP6 variants in patients with early-onset osteoporosis (EOOP).
    J Bone Miner Res. 2020 Oct 29. doi: 10.1002/jbmr.4197.
    PubMed     Abstract available


  154. ZENGIN A, Jarjou LM, Janha RE, Prentice A, et al
    Sex-specific associations between cardiac workload, peripheral vascular calcification and bone mineral density: The Gambian Bone and Muscle Ageing Study.
    J Bone Miner Res. 2020 Oct 29. doi: 10.1002/jbmr.4196.
    PubMed     Abstract available


  155. BURT LA, Billington EO, Rose MS, Kremer R, et al
    Reply to Effects of High-Dose Vitamin D Supplementation on Bone Fragility.
    J Bone Miner Res. 2020 Oct 23. doi: 10.1002/jbmr.4190.
    PubMed    


  156. WARD KA
    Bone Loss and Lactation in Women Living With HIV: Potential Implications for Long-Term Bone Health.
    J Bone Miner Res. 2020 Oct 5. doi: 10.1002/jbmr.4183.
    PubMed    


    May 2020
  157. SAAG KG, Curtis JR, Reid IR
    Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide.
    J Bone Miner Res. 2020;35:996-997.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: